C4 Therapeutics (CCCC) Net Cash Flow Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | -216.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -216.90% |
| Dec 31, 2025 | 480.58% |
| Sep 30, 2025 | -43.69% |
| Jun 30, 2025 | 262.37% |
| Mar 31, 2025 | 88.61% |
| Dec 31, 2024 | -106.33% |
| Sep 30, 2024 | -182.79% |
| Jun 30, 2024 | -260.07% |
| Mar 31, 2024 | -287.26% |
| Dec 31, 2023 | 431.40% |
| Sep 30, 2023 | 310.01% |
| Jun 30, 2023 | -140.69% |
| Mar 31, 2023 | 165.48% |
| Dec 31, 2022 | 76.60% |
| Sep 30, 2022 | 93.46% |
| Jun 30, 2022 | -93.89% |
| Mar 31, 2022 | 65.31% |
| Dec 31, 2021 | -171.53% |
| Sep 30, 2021 | -167.77% |
| Jun 30, 2021 | 447.19% |
| Mar 31, 2021 | -420.04% |
| Dec 31, 2020 | 1,234.81% |